首页> 外文期刊>World Journal of Gastroenterology >Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles
【24h】

Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles

机译:口服壳聚糖-DNA纳米颗粒介导的体内转染mEpo基因到肠上皮

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To prepare the chitosan-pmEpo nanoparticles and to study their ability for transcellular and paracellular transport across intestinal epithelia by oral administration. METHODS: ICR mice were fed with recombinant plasmid AAV-tetO-CMV-mEpo (containing mEpo gene) or pCMVβ (containing LacZ gene), whether it was wrapped by chitosan or no. Its size and shape were observed by transmission electron microscopy. Agarose gel electrophoresis was used to assess the efficiency of encapsulation and stability against nuclease digestion. Before and after oral treatmant, blood samples were collected by retro-orbital puncture, and hematocrits were used to show the physiological effect of mEpo. RESULTS: Chitosan was able to successfully wrap the plasmid and to protect it from DNase degradation. Transmission electron microscopy showed that freshly prepared particles were approximately 70-150 nm in size and fairly spherical. Three days after fed the chitosan-pCMVβ complex was fed, the mice were killed and most of the stomach and 30% of the small intestine were stained. Hematocrit was not modified in naive and 'naked' mEpo-fed mice, a rapid increase of hematocrit was observed during the first 4 days of treatment in chitosan-mEpo-fed animals, reaching 60.9+-1.2% (P<0.01), and sustained for a week. The second feed (6 days after the first feed) was still able to promote a second hematocrit increase in chitosan-mEpo-fed animals, reaching 65.9+-1.4% (P<0.01), while the second hematocrit increase did not appear in the 'naked' mEpo-second-fed mice. CONCLUSION: Oral chitosan-DNA nanoparticles can efficiently deliver genes to enterocytes, and may be used as a useful tool for gene transfer.
机译:目的:制备壳聚糖-pmEpo纳米颗粒,并研究其口服给药跨小肠上皮细胞的跨细胞和旁细胞转运的能力。方法:给ICR小鼠饲喂重组质粒AAV-tetO-CMV-mEpo(包含mEpo基因)或pCMVβ(包含LacZ基因),无论是否被壳聚糖包裹。通过透射电子显微镜观察其大小和形状。琼脂糖凝胶电泳用于评估封装效率和针对核酸酶消化的稳定性。口服治疗前后,通过眼眶后穿刺收集血样,并用血细胞比容显示mEpo的生理作用。结果:壳聚糖能够成功包裹质粒并保护其免受DNase降解。透射电子显微镜显示,新制备的颗粒的尺寸约为70-150nm,并且相当球形。饲喂壳聚糖-pCMVβ复合物后三天,处死小鼠,并对大部分胃和30%的小肠染色。幼稚和“裸露” mEpo喂养的小鼠中的血细胞比容没有改变,在壳聚糖-mEpo喂养的动物中治疗的前4天中观察到血细胞比容快速增加,达到60.9 + -1.2%(P <0.01),并且持续了一周。在壳聚糖-mEpo喂养的动物中,第二次饲喂(第一次饲喂后6天)仍然能够促进第二次血细胞比容升高,达到65.9 + -1.4%(P <0.01),而第二次却没有出现血细胞比容升高。 mEpo二次喂养的“裸”小鼠。结论:口服壳聚糖DNA纳米粒子可以有效地将基因传递到肠上皮细胞,可以用作基因转移的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号